Close

Needham & Company Reiterates a 'Buy' on Intermolecular (IMI); 4Q11 Results and Expansion of Guardian Contract Highlight Progress

February 8, 2012 8:10 AM EST
Get Alerts IMI Hot Sheet
Price: $1.20 --0%

Rating Summary:
    2 Buy, 5 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 12 | Down: 10 | New: 14
Join SI Premium – FREE
Needham & Company reiterates a 'Buy' on Intermolecular (NASDAQ: IMI) price target of $13.00.

Analyst, Y. Edwin Mok, said, "IMI reported better than expected 4Q11 non-GAAP earnings, and announced the renewal and expansion of the Guardian. With substanital backlog coverage and the renewal of one of two key CDPs, we are increasingly confident about our 2012 revenue estimate. Additionally, we believe IMI is actively pursuing new micro-CDP engagements within the semiconductor markets and beyond. We see several positive catalysts coming in the next few months, and suggest investors buy IMI."

"We raise our 2012 non-GAAP EPS to $0.01 on slightly higher revenue, and keep our 2013 rev/non-GAAP EPS unchanged at $105MM/$0.63."

For an analyst ratings summary and ratings history on Intermolecular click here. For more ratings news on Intermolecular click here.

Shares of Intermolecular closed at $9.01 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View

Related Entities

Needham & Company, Earnings